MicroRNA as Markers in Testicular Cancer
Abroad (travel likely)Recruiting
Conditions
Testicular Germ Cell Cancer · Seminoma · Non-Seminoma Testicular Cancer · Stage I Testicular Cancer · Stage II Testicular Cancer · Stage III Testicular Cancer · Stage IV Testicular Cancer · Relapse Testicular Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Haukeland University Hospital, Bergen, Norway
Contact: Study coordinator (Mette Pernille Myklebust, PhD) · mette.pernille.myklebust@helse-bergen.no · +47 41684492Haugesund Hospital, Haugesund, Norway
Contact: Study coordinator (Bogdan Stefan Bercea, MD) · bogdan.stefan.bercea@helse-fonna.no · +47 52 73 20 00Oslo University Hospital, Oslo, Norway
University Hospital of North Norway, Tromsø, Norway
Contact: Study coordinator (Hege S. Haugnes, MD, PhD) · hege.sagstuen.haugnes@unn.no · +47 77 75 43 42Sahlgrenska University Hospital, Gothenburg, Sweden
Contact: Study coordinator (Anna G. Bergdahl, MD, PhD) · anna.grenabo@vg.region.se · +46 31 342 90 26Karolinska University Hospital, Stockholm, Sweden
Study leads
Mette Pernille Myklebust, PhD
Principal Investigator
Haukeland University Hospital